Core Viewpoint - American Water Works Company (AWK) is set to release its third-quarter 2025 results on October 29, following a negative earnings surprise of 0.67% in the previous quarter [1] Factors Impacting Q3 Performance - AWK generates nearly 100% of its net income from regulated operations, with new rates effective from January 1, 2025, expected to positively influence quarterly performance [2] - Ongoing infrastructure improvements due to capital investments and efficient cost management strategies are anticipated to benefit earnings, along with incremental interest income [3] - The company completed six acquisitions in three states by June 30, 2025, with additional acquisitions in Q3 likely contributing positively to earnings through synergies [3] Q3 Expectations for AWK - The Zacks Consensus Estimate for earnings is projected at $1.89 per share, reflecting a year-over-year increase of 5% [4] - Revenue estimates are set at $1.32 billion, indicating a slight decline of 0.19% compared to the previous year [4] Earnings Prediction Model - The current model does not predict an earnings beat for AWK, as the company has an Earnings ESP of 0.00% and a Zacks Rank of 4 (Sell) [5][6]

Core Insights - Willis Towers Watson Public Limited Company (WTW) is anticipated to show an improvement in its bottom line while experiencing a decline in its top line for the third quarter of 2025, with revenues expected to be $2.28 billion, reflecting a 0.5% decrease year-over-year [1] Revenue Expectations - The consensus estimate for WTW's third-quarter earnings is $3.00 per share, indicating a year-over-year increase of 2.3% [2] - Revenue growth is expected to be driven by strong performances across all segments, particularly in Health and Wealth, aided by new business wins and client retention [5][10] Segment Performance - The Wealth business is likely to benefit from increased Retirement work globally and growth in Investments due to new business and product launches [6] - The Benefits Delivery & Outsourcing segment is expected to see growth from increased project and core administration work in Europe, although this may be offset by lower commission revenues in the individual marketplace [7] - Corporate Risk & Broking is projected to benefit from strong business generation and global specialization, contributing to overall revenue growth [8] Expense Outlook - Expenses for the third quarter are expected to rise to $1.8 billion, driven by higher incentive costs, salary expenses, and losses on professional liability claims [9]

Corebridge Financial Overview - Wall Street anticipates a year-over-year decline in earnings for Corebridge Financial (CRBG) despite higher revenues, with earnings expected to be $1.09 per share, reflecting a -21% change, while revenues are projected at $4.62 billion, up 2% from the previous year [3][12] - The earnings report is scheduled for November 3, and actual results that exceed expectations could lead to a stock price increase, while missing estimates may result in a decline [2][12] Estimate Revisions and Earnings ESP - The consensus EPS estimate has been revised down by 2.62% over the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4][12] - Corebridge's Earnings ESP stands at -1.63%, suggesting that the Most Accurate Estimate is lower than the Zacks Consensus Estimate, complicating predictions of an earnings beat [12] Earnings History and Market Sentiment - Corebridge has a history of beating consensus EPS estimates, having surpassed expectations in the last four quarters, including a +18.26% surprise in the most recent quarter [13][14] - Despite this positive history, the current combination of a negative Earnings ESP and a Zacks Rank of 3 makes it challenging to predict a beat for the upcoming report [12][17] Industry Context - In comparison, SiriusPoint (SPNT), another player in the Zacks Insurance - Multi line industry, is expected to report earnings of $0.51 per share, indicating no change year-over-year, with revenues projected at $727.2 million, up 29.4% [18][19] - SiriusPoint's consensus EPS estimate has been revised down by 4.1% over the last 30 days, and it currently holds an Earnings ESP of 0%, making predictions of an earnings beat similarly uncertain [19][20]

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for BWX Technologies (BWXT) due to higher revenues, with a focus on how actual results will compare to estimates [1][2]. Earnings Expectations - BWXT is expected to report quarterly earnings of $0.85 per share, reflecting a year-over-year increase of 2.4%, and revenues are projected to be $796.38 million, up 18.5% from the previous year [3]. - The earnings report is scheduled for release on November 3, and better-than-expected results could lead to a stock price increase, while disappointing results may cause a decline [2]. Estimate Revisions - The consensus EPS estimate has been revised 1.79% higher in the last 30 days, indicating a reassessment by analysts [4]. - BWXT's Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -2.43%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - BWXT currently holds a Zacks Rank of 2, but the negative Earnings ESP complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, BWXT exceeded expectations by posting earnings of $1.02 per share against an expected $0.79, resulting in a surprise of 29.11% [13]. - The company has beaten consensus EPS estimates in all of the last four quarters [14]. Conclusion - While BWXT does not appear to be a strong candidate for an earnings beat, investors should consider other factors before making investment decisions [17].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Capital Southwest (CSWC) despite higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - CSWC is expected to report quarterly earnings of $0.58 per share, reflecting a year-over-year decrease of 12.1%, while revenues are projected to be $55.74 million, an increase of 14.4% from the previous year [3]. - The consensus EPS estimate has been revised down by 0.84% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that CSWC has a negative Earnings ESP of -5.71%, suggesting a bearish outlook from analysts [12]. - The stock currently holds a Zacks Rank of 4, making it challenging to predict an earnings beat [12]. Historical Performance - In the last reported quarter, CSWC met the expected earnings of $0.59 per share, resulting in no surprise [13]. - Over the past four quarters, CSWC has only surpassed consensus EPS estimates once [14]. Industry Comparison - In the Zacks Financial - Investment Management industry, T. Rowe Price (TROW) is expected to report earnings of $2.49 per share, a year-over-year decline of 3.1%, with revenues anticipated at $1.86 billion, up 3.9% [18]. - T. Rowe's consensus EPS estimate has been revised up by 3.4% in the last 30 days, but it currently has an Earnings ESP of 0% [19].

Core Viewpoint - The market anticipates a year-over-year decline in earnings for Diamondback Energy (FANG) despite higher revenues when it reports its results for the quarter ended September 2025 [1][3]. Earnings Expectations - Diamondback is expected to report quarterly earnings of $2.79 per share, reflecting a year-over-year decrease of 17.5% [3]. - Revenues are projected to reach $3.42 billion, which is an increase of 29.1% compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 4.75% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Diamondback is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +4.26% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive reading indicates a likely earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - Diamondback currently holds a Zacks Rank of 3, suggesting a potential to beat the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Diamondback exceeded the expected earnings of $2.63 per share by delivering $2.67, resulting in a surprise of +1.52% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [14]. Industry Context - In the broader industry context, CNX Resources Corporation is expected to post earnings of $0.4 per share for the quarter ended September 2025, indicating a year-over-year change of -2.4% [18]. - CNX Resources' revenue is projected to be $385.67 million, up 9% from the previous year, but it has a negative Earnings ESP of -5.32% [19][20].

Core Viewpoint - Exact Sciences (EXAS) is expected to report a year-over-year increase in earnings and revenues for the quarter ended September 2025, with a consensus outlook indicating a significant earnings surprise potential [1][3][12]. Earnings Expectations - The consensus EPS estimate for Exact Sciences is $0.10 per share, reflecting a year-over-year increase of +147.6% [3]. - Revenues are projected to be $809.93 million, which is a 14.3% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 9.76% higher in the last 30 days, indicating a positive reassessment by analysts [4]. - The Most Accurate Estimate for Exact Sciences is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +56.25% [12]. Earnings Surprise Prediction - A positive Earnings ESP reading suggests a strong likelihood of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy) [10][12]. - Exact Sciences currently holds a Zacks Rank of 1, reinforcing the expectation of surpassing the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Exact Sciences exceeded the expected loss of $0.02 per share by reporting earnings of $0.22, resulting in a surprise of +1,200.00% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [14]. Industry Context - Apellis Pharmaceuticals (APLS), another player in the Zacks Medical - Biomedical and Genetics industry, is expected to report earnings of $0.83 per share, indicating a year-over-year change of +280.4% [18]. - Apellis Pharmaceuticals has an Earnings ESP of +33.59% and a Zacks Rank of 3 (Hold), suggesting a likelihood of beating the consensus EPS estimate [19][20].

Core Viewpoint - Freshpet (FRPT) is anticipated to report a year-over-year increase in earnings driven by higher revenues, with the actual results being a significant factor influencing its near-term stock price [1][2]. Financial Expectations - The upcoming earnings report is expected to reveal quarterly earnings of $0.43 per share, reflecting a year-over-year increase of +79.2% [3]. - Revenues are projected to reach $284.53 million, which is a 12.3% increase compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 8.07% over the last 30 days, indicating a reassessment by analysts [4]. - Despite the downward revision, the Most Accurate Estimate for Freshpet is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +1.04% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive Earnings ESP reading is a strong predictor of an earnings beat, particularly when combined with a favorable Zacks Rank [10]. - Freshpet currently holds a Zacks Rank of 5 (Strong Sell), complicating the prediction of an earnings beat despite the positive Earnings ESP [12][20]. Historical Performance - In the last reported quarter, Freshpet exceeded the expected earnings of $0.12 per share by delivering $0.33, resulting in a surprise of +175.00% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates two times [14]. Industry Comparison - Kraft Heinz (KHC), another player in the food industry, is expected to report earnings of $0.57 per share, indicating a year-over-year decline of -24% [18]. - Kraft Heinz's revenues are projected to be $6.25 billion, down 2.1% from the previous year, with a recent EPS estimate revision of 0.9% downward [19].

Core Insights - Wall Street anticipates a year-over-year increase in earnings for Hims & Hers Health, Inc. (HIMS) driven by higher revenues, with a consensus EPS estimate of $0.09, reflecting a 50% increase from the previous year, and revenues expected to reach $583.68 million, up 45.4% year-over-year [1][3] Earnings Expectations - The upcoming earnings report is scheduled for November 3, and the stock may rise if actual results exceed expectations, while a miss could lead to a decline [2] - The consensus EPS estimate has been revised down by 3.96% over the last 30 days, indicating a reassessment by analysts [4] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Hims & Hers is lower than the consensus, resulting in an Earnings ESP of -12.79%, suggesting a bearish outlook from analysts [12] - The stock currently holds a Zacks Rank of 3, complicating predictions of an earnings beat [12] Historical Performance - In the last reported quarter, Hims & Hers was expected to post earnings of $0.18 per share but delivered $0.17, resulting in a surprise of -5.56% [13] - Over the past four quarters, the company has only beaten consensus EPS estimates once [14] Industry Comparison - Another player in the Zacks Medical Info Systems industry, Omnicell (OMCL), is expected to report earnings of $0.36 per share, reflecting a year-over-year decrease of 35.7%, with revenues projected at $294.06 million, up 4.1% [18] - Omnicell's consensus EPS estimate has been revised up by 8.2% in the last 30 days, but it also has a negative Earnings ESP of -13.89%, making predictions of an earnings beat challenging [19][20]

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Hologic, with a focus on how actual results compare to estimates, which could significantly impact stock price [1][2]. Earnings Expectations - Hologic is expected to report earnings of $1.10 per share, reflecting an 8.9% increase year-over-year [3][18]. - Revenue is projected to be $1.03 billion, representing a 4.7% increase from the previous year [3][19]. Estimate Revisions - The consensus EPS estimate has been revised down by 1.38% over the last 30 days, indicating a reassessment by analysts [4][19]. - The Most Accurate Estimate matches the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, complicating predictions of an earnings beat [12][19]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with a strong predictor of earnings beats when combined with a favorable Zacks Rank [9][10]. - Hologic currently holds a Zacks Rank of 3 (Hold), making it challenging to predict an earnings beat conclusively [12][20]. Historical Performance - In the last reported quarter, Hologic exceeded the expected earnings of $1.05 per share, achieving $1.08, resulting in a surprise of +2.86% [13]. - Over the past four quarters, Hologic has surpassed consensus EPS estimates three times [14][20]. Conclusion - While Hologic is not positioned as a compelling earnings-beat candidate, investors should consider other factors when making decisions regarding the stock ahead of the earnings release [17][20].